I. Menshikova

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

R. Moots, P. Emery, D. Mevorach, 2017, The Lancet.

Fast Track to Full Online Education in the Medical Field

V. Beketov, I. Menshikova, Anastasiya Khudarova, 2022, International Journal of Web-Based Learning and Teaching Technologies.

The study of cardiotoxicity of hydroxychloroquine and azithromycine combination in hospitalized patients with COVID-19

Y. Belenkov, I. Ilgisonis, I. Menshikova, 2020, Sechenov Medical Journal.

Post hoc analysis of the results of KOLIBRI comparative observational clinical study in patients with knee and small hand joints osteoarthritis

A. Sukhinina, V. Sorotskaya, A. Feklistov, 2022, Modern Rheumatology Journal.

A chat-bot in rheumatoid arthritis treatment control

I. Menshikova, E. Zheleznykh, Yuliya A. Prokofeva, 2023, Digital Diagnostics.

SAT0230 Comparison of efficacy of tofacitinib vs. etanercept treatment in rheumatoid arthtritis patients with high activity disease by ultrasound evaluation with power doppler (1 YEAR TREATMENT PERIOD).

I. Menshikova, I. Kolosova, Y. Pak, 2018, Saturday, 16 JUNE 2018.

Immune-mediated adverse rheumatic reactions following administration of immune checkpoint inhibitors

I. Menshikova, V. Strogonova, 2020, Rheumatology Science and Practice.